Core Viewpoint - Rongke Technology's stock has shown significant volatility, with a year-to-date increase of 36.76% but a recent decline of 11.54% over the past five trading days [1] Financial Performance - As of June 30, 2025, Rongke Technology reported a revenue of 292 million yuan, a year-on-year decrease of 7.01%, and a net profit attributable to shareholders of -27.23 million yuan, a decline of 576.78% [2] - The company has cumulatively distributed 99.14 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3] Stock Market Activity - On September 24, 2023, Rongke Technology's stock price reached 27.83 yuan per share, with a trading volume of 264 million yuan and a turnover rate of 1.52%, resulting in a total market capitalization of 17.804 billion yuan [1] - The stock has appeared on the "Dragon and Tiger List" once this year, with a net purchase of 141 million yuan on August 13, 2023 [1] Shareholder Information - As of June 30, 2025, the number of shareholders for Rongke Technology was 60,600, a decrease of 6.30% from the previous period, with an average of 10,556 shares held per shareholder, an increase of 6.76% [2] - The fourth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 2.0079 million shares, a decrease of 21,000 shares from the previous period [3] Business Overview - Rongke Technology, established on November 18, 2005, and listed on February 16, 2012, operates in smart healthcare, health data, and intelligent cloud services [1] - The company's main business revenue composition is 73.25% from self-developed products and services, 26.64% from system integration, and 0.12% from other sources [1][2]
荣科科技涨2.02%,成交额2.64亿元,主力资金净流入511.16万元